A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 3, 2008, Pages 172-176

  Abraham, Clara ^a,b   Hart, John ^b   Locke, Susan M ^c   Baker, Alfred L ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c West Suburban Medical Center   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FUROSEMIDE; INDOMETACIN; KETOPROFEN; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RANITIDINE; SPIRONOLACTONE;

ABDOMINAL PAIN; ACUTE HEPATITIS; ADD ON THERAPY; ADULT; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BONE PAIN; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; HYPERTENSION; JAUNDICE; LIVER BIOPSY; MULTIPLE CYCLE TREATMENT; NAUSEA; PANCYTOPENIA; PARACENTESIS; PRIORITY JOURNAL; SIDE EFFECT; URINE; VOMITING;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE PROGRESSION; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, CHRONIC, DRUG-INDUCED; HUMANS; INDOMETHACIN; MIDDLE AGED; OSTEOARTHRITIS, HIP;

EID: 40449136016     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1055     Document Type: Article

References (16)

1. Rodriguez LAG (1994) Acute liver injury associated with nonsteroidal ant-inflammatory drugs and the role of risk factors. Arch Intern Med 154: 311-316
2. Dissing M and Andreasen PB (1982) Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to The Danish Board of Adverse Reactions to Drugs. Scand J Gastroenterol 17: 205-211
3. Kromann-Andersen H and Pedersen A (1988) Reported adverse reactions to and consumption of nonsteroidal anti-inflammatory drugs in Denmark over a 17-year period. Dan Med Bull 35: 187-192
4. Carson JL et al. (1993) Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med 153 1331-1336
5. Cappell MS et al. (1988) Indomethacin-associated cholestasis. J Clin Gastroenterol 10: 445-447
6. Kelsey WM and Scharyj M (1967) Fatal hepatitis probably due to indomethacin. J Am Med Assoc 199: 586-587
7. Fenech FF et al. (1967) Hepatitis with biliverdinaelemia in association with indomethacin therapy. Br Med J 3: 155-156
8. De Kraker-Sangster M et al. (1981) Massive liver cell necrosis following administration of indomethacin in combination with aminophenzone [Dutch]. Ned T Geneesk 125: 1828-1831
9. Opolon P et al. (1969) Application of the lymphoblastic transformation test (LTT) to the diagnosis of drug-induced hepatitis [French]. La Presse Medicale 77: 2041-2043
10. Jacobs JC (1967) Sudden death in arthritic children receiving large doses of indomethacin. J Am Med Assoc 199: 932-934
11. Burke A et al. (2006) Analgesic-antipyretic and antiinflammatory agents; pharmacotherapy df gout. In Goodman and Gilman's: The Pharmacological Basis of Therapeutics, edn 11, 671-716 (Eds Brunton L et al.) New York: McGraw-Hill
12. Aithal PG and Day CP (1999) The natural history of histologically proved drug induced liver disease. Gut 44: 731-735
13. Lee WM (2003) Drug-induced hepatotoxicity. N Engl J Med 349: 474-485
14. Czaja AJ and Donaldson PT (2000) Genetic susceptibilities for immune expression and-liver cell injury in autoimmune hepatitis. Immunol Rev 174: 250-259
15. Kammer AR et al. (1999) Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 190: 169-176
16. Peterson DA et al. (1999) Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11: 453-462